Figure 6.(A) Trolox equivalent antioxidant capacity (TEAC) levels in blood from patients treated with calcineurin inhibitor (CNi) or CNi + mTOR inhibitor (CNi+mTORi). (B) Glutathione peroxidase (GPx) activity in peripheral blood mononuclear cells (PBMC) from patients treated with CNi or CNi+mTORi. Statistical difference was assessed by unpaired student’s t-test.
